Corum Inc. highlights its work in NGS (next-generation sequencing) and epigenetics to repair damaged and weakened skin with the development of Epi-On (INCI: Azelamidopropyl Dimethyl Amine (and) Water (Aqua) (and) Butylene Glycol).
Epi-On is a patented active that aims to protect skin and accelerate tissue repair mechanisms through epigenetic regulation. It can be used in treatment products targeting post-acne and post-procedure recoveries to help restore weakened and damaged skin, as well as lighten the appearance of marks.
A clinical study after the laser resurfacing of skin reportedly showed that Epi-On has the ability to reduce inflamed skin, provide relief and accelerate skin healing for irritated and sensitive skin. The company notes additional benefits include: P. acne inhibition; anti-inflammation; control of sebum production; solubility in water and other chemicals; compatibilty with cosmetic ingredients; and safety.
For more information, contact Corum Inc.